United Labs & Novo Nordisk Sign $2B Deal for Obesi...
Category : Licensing/Collaboration Deal 25 March 2025An exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glu...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Yaqrit Secures £2.2M NIHR Grant for Dialive Liver...
Category : Approval/Launch 25 March 2025Yaqrit, a late clinical-stage company developing life-saving treatments for advanced liver diseases,...
Health Canada Approves Hikma’s Kloxxado Nasal Spra...
Category : Approval/Launch 25 March 2025Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announce...
Tempero Bio Starts Phase 2 Trial with TMP-301 for...
Category : Clinical Trial Update 25 March 2025Nxera Pharma Co., Ltd. announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of...
Pharming Doses First Patient in Phase II Trial of...
Category : Clinical Trial Update 24 March 2025Pharming Group NV, a global biopharmaceutical company dedicated to transforming the lives of patient...
Latest Newsletter Post
-
Tempero Bio Starts Phase 2 Trial wi..
25 March 2025
-
Health Canada Approves Hikma’s Klox..
25 March 2025
-
Yaqrit Secures £2.2M NIHR Grant for..
25 March 2025
-
United Labs & Novo Nordisk Sign $2B..
25 March 2025
-
Alnylam Wins FDA Approval for AMVUT..
24 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com